Spyre Therapeutics, Inc.SYRENASDAQ
Loading
Capital Expenditure Over TimeStrong
Percentile Rank82
Studio
Year-over-Year Change

Cash spent on acquiring or upgrading physical assets

Latest
$0.00
↑ 100% vs avg
Percentile
P82
Within normal range
Average
$-763600.00
Historical baseline
PeriodValueYoY Change
TTM$0.00-
2024$0.00-
2023$0.00+100.0%
2022$-38000.00+93.4%
2021$-573000.00+86.6%
2020$-4.28M-186.9%
2019$-1.49M-253.6%
2018$-422000.00+31.8%
2017$-619000.00-192.0%
2016$-212000.00-